LNTH

#1119
Lantheus Holdings, Inc
74.9100
-1.06%
Setor:
Base:
Moeda do lucro:
Faixa diária
74.9100
74.9100
Faixa anual
50.1550
80.9100
Mudança diária
-1.06%
Mudança mensal
+9.98%
Mudança em 6 meses
+33.62%
Mudança anual
+33.62%
Fechamento anterior
75.7150
Open
74.9100
Bid
Ask
Low
74.9100
High
74.9100
Volume
194
Open full chart

Financials

Overview Relatórios Statistics Dividends
Quarterly Annual
  • Market Capitalization 5.0556 B
  • Employee 808
  • Founded N/A
  • CEO N/A
  • Website www.lantheus.com
  • Headquarter Delaware, United States
  • FIGI BBG006Q52RD0
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
19.52
Price to sales ratio
—
Dividends per share
—
Dividend yield %
—

Lantheus Holdings Inc

Lantheus, headquartered in Billerica, Massachusetts, is a company in the radiopharmaceuticals business. It has strategic partnerships with Bayer, Novartis, Regeneron as well as GE Healthcare and Siemens Healthineers. Lantheus Holding, which became a NASDAQ company in 2015, is the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc. and EXINI Diagnostics AB. Lantheus has offices in Massachusetts, New Jersey, Canada and Sweden. Brian Markison has served as the company's CEO since March 1, 2024, following the retirement of Mary Anne Heino, who had led Lantheus for the preceding decade.

Notícias